Joel Becker - 27 Feb 2025 Form 4 Insider Report for NeuroPace Inc (NPCE)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Leah Akin, Attorney-in-Fact
Issuer symbol
NPCE
Transactions as of
27 Feb 2025
Transactions value $
-$56,595
Form type
4
Filing time
20 Mar 2025, 17:16:10 UTC
Previous filing
28 Feb 2024
Next filing
29 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NPCE Common Stock Tax liability -$56.6K -4.51K -8.59% $12.56 48K 27 Feb 2025 Direct
transaction NPCE Common Stock Award $0 +58.5K +121.97% $0.00 106K 10 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NPCE Stock Option (Rt to Buy) Award $0 +99.2K $0.00 99.2K 10 Mar 2025 Common Stock 99.2K $10.04 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on March 3, 2026 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.
F2 25% of the shares subject to the option vest on March 3, 2026. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter.